Medifast Inc (MED) stock
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3067% below fair value
$11.75−0.23 (-1.92%)
Close on Nov 20, 2026Market cap $131.40MP/E –Yield 0.00%
Medifast gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Medifast's gross profit for the twelve months ending Sep 30, 2026 was $207.33M, down 33.4% year over year. For fiscal 2025 it was $275.19M, down 38.1% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is $1.14B in fiscal 2022.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $275.19M | -38.1% |
| FY2024 | Dec 31, 2024 | $444.62M | -42.7% |
| FY2023 | Dec 31, 2023 | $775.85M | -32.0% |
| FY2022 | Dec 31, 2022 | $1.14B | +1.1% |
| FY2021 | Dec 31, 2021 | $1.13B | +61.6% |
| FY2020 | Dec 31, 2020 | $697.82M | +30.0% |
| FY2019 | Dec 31, 2019 | $536.86M | +41.3% |
| FY2018 | Dec 31, 2018 | $379.90M | +66.8% |
| FY2017 | Dec 31, 2017 | $227.81M | +10.8% |
| FY2016 | Dec 31, 2016 | $205.66M | +2.2% |
| FY2015 | Dec 31, 2015 | $201.32M | -3.8% |
| FY2014 | Dec 31, 2014 | $209.21M | -13.0% |
| FY2013 | Dec 31, 2013 | $240.57M | +2.0% |
| FY2012 | Dec 31, 2012 | $235.91M | +5.1% |
| FY2011 | Dec 31, 2011 | $224.50M | +16.6% |
| FY2010 | Dec 31, 2010 | $192.47M | +54.7% |
| FY2009 | Dec 31, 2009 | $124.39M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $50.04M | -19.5% |
| Q2 FY2026 | Jun 30, 2026 | $53.40M | -30.3% |
| Q1 FY2026 | Mar 31, 2026 | $51.76M | -38.6% |
| Q4 FY2025 | Dec 31, 2025 | $52.14M | -40.9% |
| Q3 FY2025 | Sep 30, 2025 | $62.16M | -41.2% |
| Q2 FY2025 | Jun 30, 2025 | $76.64M | -37.9% |
| Q1 FY2025 | Mar 31, 2025 | $84.25M | -33.8% |
| Q4 FY2024 | Dec 31, 2024 | $88.22M | -37.6% |
| Q3 FY2024 | Sep 30, 2024 | $105.67M | -40.4% |
| Q2 FY2024 | Jun 30, 2024 | $123.44M | -41.4% |
| Q1 FY2024 | Mar 31, 2024 | $127.29M | -48.3% |
| Q4 FY2023 | Dec 31, 2023 | $141.37M | -39.5% |
| Q3 FY2023 | Sep 30, 2023 | $177.38M | -37.3% |
| Q2 FY2023 | Jun 30, 2023 | $210.72M | -34.5% |
| Q1 FY2023 | Mar 31, 2023 | $246.39M | -18.5% |
| Q4 FY2022 | Dec 31, 2022 | $233.60M | -16.1% |
| Q3 FY2022 | Sep 30, 2022 | $282.85M | -7.9% |
| Q2 FY2022 | Jun 30, 2022 | $321.68M | +9.5% |
| Q1 FY2022 | Mar 31, 2022 | $302.29M | +21.6% |
| Q4 FY2021 | Dec 31, 2021 | $278.29M | +39.7% |
| Q3 FY2021 | Sep 30, 2021 | $307.06M | +50.5% |
| Q2 FY2021 | Jun 30, 2021 | $293.71M | +84.4% |
| Q1 FY2021 | Mar 31, 2021 | $248.55M | +83.8% |
| Q4 FY2020 | Dec 31, 2020 | $199.24M | +55.6% |
| Q3 FY2020 | Sep 30, 2020 | $204.04M | +42.7% |
| Q2 FY2020 | Jun 30, 2020 | $159.30M | +13.2% |
| Q1 FY2020 | Mar 31, 2020 | $135.24M | +8.1% |
| Q4 FY2019 | Dec 31, 2019 | $128.07M | +17.4% |
| Q3 FY2019 | Sep 30, 2019 | $142.93M | +33.3% |
| Q2 FY2019 | Jun 30, 2019 | $140.71M | +58.5% |
| Q1 FY2019 | Mar 31, 2019 | $125.15M | +67.3% |
| Q4 FY2018 | Dec 31, 2018 | $109.09M | +84.5% |
| Q3 FY2018 | Sep 30, 2018 | $107.20M | +84.2% |
| Q2 FY2018 | Jun 30, 2018 | $88.80M | +54.1% |
| Q1 FY2018 | Mar 31, 2018 | $74.81M | +41.4% |
| Q4 FY2017 | Dec 31, 2017 | $59.13M | +25.6% |
| Q3 FY2017 | Sep 30, 2017 | $58.18M | – |
| Q2 FY2017 | Jun 30, 2017 | $57.61M | – |
| Q1 FY2017 | Mar 31, 2017 | $52.89M | – |
| Q4 FY2016 | Dec 31, 2016 | $47.08M | – |
See a number that looks wrong?